The global demand for Opioid Analgesics Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.
The phrase opioid analgesics refers to pain-relieving drugs that act on opioid receptors. Compound analgesics combining acetaminophen with modest dosages of codeine or tramadol are sometimes referred to as weak opioid analgesics. Sustained-release opioids (SROs, also known as continuous-release or extended-release opioids), immediate-release opioids (IROs), and long-acting opioids (LAOs) are the three types of moderate or strong opioid analgesics.
Market Dynamics
Rising demand for post-surgery pain management, and advancements in drug formulations to lessen analgesic side effects, are projected to drive opioid analgesic market growth in the coming years. Furthermore, the rising prevalence of chronic pain and orthopaedic illnesses in the older population is pushing the opioid analgesics industry forward. Additionally, increasing disposable income and rising healthcare expenditure are two variables that are expected to promote market expansion. Opioids are widely recognized as the most effective pain relievers. Their use in chronic pain management is common to practise in many nations throughout the world. Demand for opioid analgesics is expected to rise as the incidence of cancer, orthopaedic illnesses, and neuropathic pain rises. Nevertheless, the increasing prevalence of opioid misuse is projected to hamper the expansion of the opioid analgesics industry.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of opioid analgesics. The growth and trends of opioid analgesics industry provide a holistic approach to this study.
Market Segmentation
This section of the opioid analgesics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Drug Class
- Morphine
- Codeine
- Fentanyl
- Meperidine
- Methadone
- Tramadol
- Oxycodone
- Dextromethorphan
- Buprenorphine
- Others
By Indication
- Surgical Pain
- Cancer Pain
- Neuropathic Pain
- Other
By Route Of Administration
- Oral
- Parenteral
- Transdermal
- Other
By End User
- Hospitals
- Retail Pharmacies
- Drug Stores
- Online Pharmacies
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Opioid Analgesics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Opioid Analgesics Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the opioid analgesics market include Pfizer Inc, Abbott Laboratories, Janssen Pharmaceuticals, Inc., Johnson & Johnson, Novartis AG, Bayer AG, GlaxoSmithKline plc, F. Hoffmann-La Roche AG, Boehringer Ingelheim International GmbH, Bausch Health Companies Inc., and Sanofi S.A. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.